An observational study in Postoperative Complications, sponsored by University of Thessaly. Completed at 1 site in Greece. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2022-12-12.
Sponsored by University of Thessaly · Observational
This study investigated the 30-day postoperative outcome after elective EVAR and the role of possible predictors among patients' baseline characteristics
The study included 322 consecutive AAA patients treated electively with EVAR from March 2016 to February 2019 at a tertiary referral center.
Early follow-up with clinical and laboratory evaluation took place at the 30rd day post-operatively. Any adverse event, such as major adverse cardiovascular events (MACE), post-implantation syndrome (PIS), acute kidney injury (AKI), and deaths of any cause were recorded.
1,233 studies on the registry are indexed under Postoperative Complications; 292 are open to participants now.
This study's enrollment of 322 is above the median of 254 across 519 observational studies indexed under Postoperative Complications.
Browse Postoperative Complications studies →University of Thessaly is the lead sponsor of 188 studies on the registry; 44 are open to participants now.
Counted across the registry records on this site, refreshed daily.
The study included consecutive AAA patients treated electively by EVAR
Exclusion Criteria:
Patients with AAA, treated electively by EVAR. The 30-day postoperative outcome after elective EVAR and the role of possible predictors among patients' baseline characteristics were assessed.
Other: 30-day postoperative outcome
The 30-day postoperative outcome after elective EVAR and the role of possible predictors among patients' baseline characteristics were assessed
Number of patients with major adverse cardiovascular events
Number of participants with major adverse cardiovascular events
Time frame: 30rd day post-operatively
Number of patients with acute kidney injury
Number of participants with acute kidney injury according to the RIFLE (Risk, Injury, Failure, Loss of kidney function, and End-stage kidney disease) criteria
Time frame: 30rd day post-operatively
Number of patients with post-implantation syndrome
Number of participants with post-implantation syndrome SIRS, without any apparent sign of infection
Time frame: 30rd day post-operatively
Deaths of any cause
Number of participants who died from any cause
Time frame: 30rd day post-operatively
Plan to share: No
No publications or documents are linked to this record.
This study is completed, as verified in Dec 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of Thessaly